Best of Cardio and Healthcare News: Week of 11/23/15

Did you have a chance to check out the latest news from the cardiology community? We've captured the top industry stories from this week that you won't want to miss.

After Obamacare implementation, public still rates healthcare good or excellent

Implementation of the Affordable Care Act (AKA Obamacare) hasn’t changed how Americans rate their healthcare, according to a new Gallup poll. More than half of the respondents rated their healthcare good or excellent, but less than 24 percent were satisfied with healthcare costs. Healthcare coverage was rated positively by only 33 percent.

Diagnostic ECG waveform reading in Carestream Vue Motion viewer cleared by FDA

The U.S. Food and Drug Administration (FDA) has given clearance for diagnostic reading of electrocardiogram (ECG) waveforms on mobile tablets and desktop displays using Carestream’s Vue Motion universal viewer. The new capability would allow physicians to give faster responses to ST segment elevation myocardial infarction (STEMI) and other serious heart conditions. It would also allow physicians to simultaneously view current and prior ECGs using tools that include pan, zoom, line measurement, caliper, and gain and speed adjustments.

Cardiac outcomes improved after using intravascular ultrasound in stent implantation

After one year, patients with long coronary lesions who were implanted with an intravascular ultrasound-guided everolimus-eluting stent had a significantly lower rate of major adverse cardiac events compared with those implanted with an angiography-guided stent, according to cardiovascularbusiness.com. “Patients were implanted with an everolimus-eluting stent (Xience prime, Abbott Vascular) for long coronary lesions and randomized to receive intravascular ultrasound-guided or angiographic-guided stent implantation immediately after their pre-PCI angiogram,” the site reports. One year later, 2.9 percent of patients undergoing intravascular ultrasound-guided stent implantation suffered major adverse cardiac events, compared with 5.8 percent of patients in the angiographic-guided group.

Cardio-diagnostic processes improve with smart ECG stethoscope attachment

Rijuven’s CardioSleeve for Pediatrics, the first device that adds electrocardiogram (ECG) capabilities to transform stethoscopes into smart, mobile-connected devices, has been cleared by the FDA. The device, which can be attached to any stethoscope, can analyze for arrhythmia or murmur and identify heart failure. 

Number and severity of migraine headaches reduced by dual antiplatelet therapy following transcatheter ASD closure

The use of dual antiplatelet therapy consisting of clopidogrel and aspirin–as opposed to aspirin alone–led to fewer and less severe migraine headaches for patients undergoing transcatheter atrial septal defect (ASD) closure. That’s according to a randomized, double-blind trial. About 15 percent of patients had new-onset migraine episodes following transcatheter ASD closure, previous studies found. 

Remote monitoring system for patients with implantable pacemakers gets FDA approval

The first app-based remote monitoring system in the U.S. for patients with implantable pacemakers–called MyCareLink Smart Monitor–was approved by the FDA on Nov. 17. The system, manufactured by Medtronic, has a mobile app that is available for free on Android and Apple platforms. It also features a handheld portable device reader.

Comments

Comments are closed on this post.
  • RSS

Statistics

  • Entries (227)
  • Comments (631)

Categories